PRESS RELEASE published on 01/07/2026 at 16:40, 1 month 14 days ago Management Appointment to Support Growth EcoGraf Limited appoints Mr John Ciganek as General Manager - Corporate Development to support growth and advance projects in Tanzania and battery anode material strategy internationally Tanzania EcoGraf Limited Corporate Development John Ciganek Battery Anode Strategy
REGULATED PRESS RELEASE published on 01/07/2026 at 16:22, 1 month 14 days ago Disclosure of Share Capital and Voting Rights as of December 31, 2025 Edenred discloses share capital and voting rights as of December 31, 2025, in accordance with French regulations. Details available on edenred.com Edenred Share Capital Voting Rights Investors French Regulations
PRESS RELEASE published on 01/07/2026 at 16:14, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group Inc. discloses a 5.07% stake in JTC plc. Purchase of 1,350 securities and sale of 8,615 securities reported Vanguard Group Stake Disclosure Securities Purchase Securities Sale JTC Plc
PRESS RELEASE published on 01/07/2026 at 16:13, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 6.02% stake in Avadel Pharmaceuticals plc. Details of purchase and sale transactions provided The Vanguard Group Purchase Sale Stake Avadel Pharmaceuticals Plc
PRESS RELEASE published on 01/07/2026 at 16:13, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.36% stake in Greencore Group plc. Additional disclosure on Bakkavor Group plc. Dealings reported on 1p ordinary shares Vanguard Group Stake Disclosure Dealings Greencore Group Plc Bakkavor Group Plc
PRESS RELEASE published on 01/07/2026 at 16:12, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.58% stake in Spire Healthcare Group plc as of 06 January 2026 in a Form 8.3 filing Form 8.3 Disclosure Vanguard Group Stake Spire Healthcare Group
PRESS RELEASE published on 01/07/2026 at 16:11, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses 5.52% stake in Dowlais Group plc on Form 8.3 under Rule 8 of the Takeover Code The Vanguard Group, Inc. Form 8.3 Rule 8.3 Takeover Code Dowlais Group Plc
PRESS RELEASE published on 01/07/2026 at 16:11, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Auction Technology Group plc The Vanguard Group, Inc. files Form 8.3 disclosing 3.55% ownership in Auction Technology Group plc. Details include securities owned and derivative transactions Form 8.3 The Vanguard Group Ownership Disclosure Securities And Derivatives Auction Technology Group PLC
PRESS RELEASE published on 01/07/2026 at 16:10, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. discloses 1.68% interest in Bakkavor Group plc's 2p ordinary shares. Additional disclosure on Greencore Group plc Securities Disclosure The Vanguard Group Interests Bakkavor Group Plc
PRESS RELEASE published on 01/07/2026 at 16:10, 1 month 14 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.93% interest in Just Group plc's 10p ordinary shares. Details of the disclosure can be found in the Form 8.3 submitted on 07-Jan-2026 Securities Form 8.3 Disclosure Vanguard Group Just Group Plc
Published on 02/21/2026 at 00:45, 1 day 9 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 10 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 11 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 12 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/22/2026 at 10:09, 30 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 22 hours 40 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/20/2026 at 18:36, 1 day 16 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 09:28, 2 days 1 hour ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 2 days 3 hours ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 2 days 3 hours ago EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON
